Cervix News and Research

RSS

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for adults with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy, irrespective of PD-L1 expression level or tumor histology.

14 Feb 2025

Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had similar effectiveness to more frequent, lower dose sessions.

11 Feb 2025

Survey shows increased use of fertility apps after Dobbs decision

The use of fertility-tracking technology increased in some states after the U.S. Supreme Court overturned Roe v. Wade despite warnings that reproduction-related data might not be secure, a new study has found.

10 Feb 2025

Biomarker test can improve neonatal outcomes for preterm births

Preterm birth - defined as delivery before the 37th week of pregnancy - is one of the leading causes of infant deaths in the United States. Babies born prematurely are also at an increased risk of having serious health problems.

3 Feb 2025

Most insurance covers IUDs. Hers cost more than $14,000.

During her annual OB-GYN visit, Callie Anderson asked about getting off the birth control pill.

31 Jan 2025

Cesarean deliveries during labor linked to risks in future pregnancies

Research links cesarean sections during labor to increased risks of recurrent preterm birth and mid-trimester loss, highlighting cervical damage concerns.

16 Dec 2024

New research highlights the role of language in pregnancy loss care

The language used in many healthcare settings to describe pregnancy loss exacerbates the grief and trauma experienced by some individuals and can be a critical factor in determining psychological well-being following the loss, according to a new report led by a UCL researcher.

9 Sep 2024

Research identifies 31 additional cancers potentially linked to obesity

This research identifies 18 potential obesity-related cancers, revealing significant associations with BMI and underscoring obesity's impact on cancer risk.

22 Aug 2024

Sensory nerves drive breast cancer growth and spread, study reveals

Cancer doesn't grow in a vacuum - each tumor grows in a particular microenvironment within the body and spreads through a tangled web of vasculature and nerves.

7 Aug 2024

Cervical mucus biomarkers could improve early detection of cervical cancer

Cervical cancer is a highly prevalent cancer, with approximately 500,000 new cases diagnosed each year.

5 Aug 2024

Groundbreaking study shows safety of outpatient labor induction for first-time mothers

In the first study of its kind, researchers at RCSI University of Medicine and Health Sciences and the Rotunda Hospital, Dublin have shown that it is safe for first-time mothers to spend the first 24 hours of induced low-risk labor in the comfort of their own homes.

29 Jul 2024

Maternity care in rural areas is in crisis. Can more doulas help?

When Bristeria Clark went into labor with her son in 2015, her contractions were steady at first. Then, they stalled.

29 Jul 2024

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state's list of controlled dangerous substances, a move that has alarmed doctors in the state.

24 Jul 2024

Canada's plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key

The impact of three priority actions of the Canadian Partnership Against Cancer (CPAC) on the time to eliminate cervical cancer in British Columbia (BC), Canada.

5 Jun 2024

Researchers develop a simpler and more effective screening method for cervical cancer

Researchers at Karolinska Institutet in Sweden and the University of Innsbruck in Austria have developed a simpler and more effective screening method for cervical cancer than the method used today.

4 Jun 2024

Cervix organ chips pave the way for next-generation studies on host-microbiome interactions

A group of researchers developed human Cervical Organ Chips to model the cervical interface.

4 Jun 2024

HPV-based screening key to eliminating cervical cancer in Canada

Implementing human papillomavirus (HPV)-based screening in British Columbia could eliminate cervical cancer in the province before 2040, according to a modeling study in CMAJ.

3 Jun 2024

Cervix-on-a-Chip: A breakthrough model for studying women's health

Bacterial Vaginosis (BV) has been identified as one of the many unmet needs in women's health and affects more than 25% of reproductive-aged women.

30 May 2024

Study shows safety of extended HPV testing intervals in cervical cancer screening

The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.

22 May 2024

Cancer history raises cardiovascular disease risk in hypertensive patients

Research reveals that individuals with hypertension and a history of cancer are at an increased risk of cardiovascular disease, with those undergoing chemotherapy facing the highest risk.

25 Apr 2024